Tailored cell-based therapies for frontotemporal dementia and related genetically defined CNS orphan indications

Project description

In situ drug delivery to the brain for CNS diseases

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › health sciences › public health
• medical and health sciences › basic medicine › neurology › dementia › alzheimer
• natural sciences › biological sciences › genetics › mutation
• medical and health sciences › basic medicine › neurology › amyotrophic lateral sclerosis

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

SINFONIA BIOTHERAPEUTICS AB

Net EU contribution

€ 50 000,00

Address

Halsovagen 7, Novum
141 57 Huddinge
Sweden

Region

Östra Sverige › Stockholm › Stockholms län

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 21 429,00